Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069520 · ClinicalTrials.gov registry record · NA
Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT04069520 is a NA study that has completed, run by Emory University. The registered enrollment target is 93 participants.
The verdict
NCT04069520, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the neural mechanisms of augmented neuromuscular training (aNMT). Participants will complete a 6-week course of neuromuscular training with either aNMT biofeedback or sham biofeedback. An MRI will be performed before and after the training program.
Interventions
- OTHER aNMT Biofeedback
- OTHER Sham Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2021-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04069520
The ClinicalTrials.gov registry entry for NCT04069520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aNMT Biofeedback is the first listed.
NCT04069520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04069520 about?
NCT04069520 is a clinical study titled "Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training". The purpose of this study is to determine the neural mechanisms of augmented neuromuscular training (aNMT). Participants will complete a 6-week course of neuromuscular training with either aNMT biofeedback or sham biofeedback. An MRI will be performed before and after the training program.
What is the current status of trial NCT04069520?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2019-06-01. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT04069520?
The interventions under investigation include: aNMT Biofeedback (OTHER), Sham Biofeedback (OTHER).
Who is sponsoring clinical trial NCT04069520?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.